The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Revance Therapeutics Inc. (RVNC) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.19, or 1.10%, to $17.44. The Revance Therapeutics Inc. has recorded 13,072 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Revance to Host Investor Day on September 19, 2023.
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $17.25 and fluctuated between $17.59 as its day high and $16.90 as its day low. The current market capitalization of Revance Therapeutics Inc. is $1.62B. A total of 1.61 million shares were traded on the day, compared to an average of 1.41M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, RVNC has seen 4 BUY and 4 SELL insider trades, representing the acquisition of 5,269 and the disposition of 56,759 shares. Over the last 12 months, there were 19 BUYs and 29 SELLs from insiders. Insiders purchased 346,855 shares during that period but sold 320,630.
In the most recent transaction, Moxie Dwight sold 11,000 shares of RVNC for 17.06 per share on Sep 06. After the transaction, the SVP, GC & Secretary now owns 44,066 company shares. In a previous transaction on Sep 05, Moxie Dwight sold 23,853 shares at 17.81 per share. RVNC shares that SVP, GC & Secretary owns now total 55,066.
Among the insiders who sold shares, Foley Mark J disposed of 26,279 shares on Aug 03 at a per-share price of $22.57. This resulted in the CEO holding 840,375 shares of RVNC after the transaction. In another insider transaction, Foley Mark J sold 26,279 shares at $24.94 per share on Jul 03. Company shares held by the CEO now total 866,654.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for RVNC in the last 3 months, the mean price target is $39.83 with high estimates of $65.00 and low estimates of $20.00. In terms of 52-week highs and lows, RVNC has a high of $37.98 and a low of $15.13.
As of this writing, RVNC has an earnings estimate of -$0.75 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.52 per share and a lower estimate of -$1.05. The company reported an EPS of -$0.74 in the last quarter, which was -5.70% lower than expectations of -$0.7.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RVNC’s latest balance sheet shows that the firm has $225.07M in Cash & Short Term Investments as of fiscal 2021. There were $324.51M in debt and $67.29M in liabilities at the time. Its Book Value Per Share was $0.32, while its Total Shareholder’s Equity was $68.47M.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RVNC is Buy with a score of 4.50.